Rees W, Bender J, Teague T K, Kedl R M, Crawford F, Marrack P, Kappler J
Howard Hughes Medical Institute, Division of Basic Immunology, National Jewish Medical and Research Center, Denver, CO 80206, USA.
Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9781-6. doi: 10.1073/pnas.96.17.9781.
Multimeric peptide/class II MHC staining reagents were synthesized and shown to bind with appropriate specificity to T cell hybridomas. A small, expanded population of T cells detected with one of these reagents in peptide-immunized C57BL/10 mice persisted for several months. This population expanded further on secondary immunization. Equating the extent of binding of this reagent to T cell receptor affinity, we saw little correlation of immunizing peptide dose to T cell receptor affinity at the peak of the primary response. However, there was an inverse relation between peptide dose and the apparent receptor affinity of the T cells that were present several months after a primary response or after a secondary stimulation either in vivo or in vitro.
多聚体肽/II类主要组织相容性复合体染色试剂已被合成,并显示出能以适当的特异性与T细胞杂交瘤结合。在肽免疫的C57BL/10小鼠中,用其中一种试剂检测到一小群扩增的T细胞持续了几个月。这群细胞在再次免疫时进一步扩增。将该试剂与T细胞受体亲和力的结合程度等同起来,我们发现在初次反应高峰期,免疫肽剂量与T细胞受体亲和力之间几乎没有相关性。然而,在初次反应后数月或体内或体外二次刺激后存在的T细胞的肽剂量与表观受体亲和力之间存在反比关系。